Search

Search Constraints

You searched for: Author/Creator Davis, Kara

Search Results

2. DIPG-15. Major tumor regressions in H3K27M-mutated diffuse midline glioma (DMG) following sequential intravenous (IV) and intracerebroventricular (ICV) delivery of GD2-CAR T-cells. (3rd June 2022)

3. EPCT-14. GD2 CAR T-CELLS MEDIATE CLINICAL ACTIVITY AND MANAGEABLE TOXICITY IN CHILDREN AND YOUNG ADULTS WITH H3K27M-MUTATED DIPG AND SPINAL CORD DMG. (1st June 2021)

5. Multi‐institutional investigation of the prognostic value of lymph nodel yield in advanced‐stage oral cavity squamous cell carcinoma. Issue 10 (13th January 2014)

7. OMIC-11. SINGLE CELL RNA SEQUENCING FROM THE CSF OF SUBJECTS WITH H3K27M+ DIPG/DMG TREATED WITH GD2 CAR T-CELLULAR THERAPY. (1st June 2021)

9. TMEM16A/ANO1 suppression improves response to antibody‐mediated targeted therapy of EGFR and HER2/ERBB2. Issue 6 (3rd April 2017)